nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A4—breast cancer	0.176	1	CbGaD
Ethosuximide—CYP3A5—Lapatinib—breast cancer	0.0397	0.0726	CbGbCtD
Ethosuximide—CYP3A4—Exemestane—breast cancer	0.0306	0.056	CbGbCtD
Ethosuximide—CYP3A7—Tamoxifen—breast cancer	0.0265	0.0484	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0265	0.0484	CbGbCtD
Ethosuximide—CYP3A4—Letrozole—breast cancer	0.0261	0.0476	CbGbCtD
Ethosuximide—CYP2E1—Tamoxifen—breast cancer	0.0256	0.0468	CbGbCtD
Ethosuximide—CYP2E1—Mitoxantrone—breast cancer	0.025	0.0456	CbGbCtD
Ethosuximide—CYP3A4—Anastrozole—breast cancer	0.0232	0.0424	CbGbCtD
Ethosuximide—CYP3A4—Toremifene—breast cancer	0.0212	0.0388	CbGbCtD
Ethosuximide—CYP3A7—Paclitaxel—breast cancer	0.0206	0.0377	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0206	0.0377	CbGbCtD
Ethosuximide—CYP3A7—Irinotecan—breast cancer	0.0204	0.0372	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0204	0.0372	CbGbCtD
Ethosuximide—CYP3A5—Tamoxifen—breast cancer	0.0199	0.0363	CbGbCtD
Ethosuximide—CYP3A4—Fulvestrant—breast cancer	0.0197	0.0361	CbGbCtD
Ethosuximide—CYP3A4—Thiotepa—breast cancer	0.0176	0.0321	CbGbCtD
Ethosuximide—CYP3A4—Ixabepilone—breast cancer	0.0161	0.0294	CbGbCtD
Ethosuximide—CYP3A4—Lapatinib—breast cancer	0.0155	0.0283	CbGbCtD
Ethosuximide—CYP3A5—Paclitaxel—breast cancer	0.0155	0.0283	CbGbCtD
Ethosuximide—CYP3A5—Irinotecan—breast cancer	0.0153	0.0279	CbGbCtD
Ethosuximide—CYP3A7—Docetaxel—breast cancer	0.0149	0.0273	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.0149	0.0273	CbGbCtD
Ethosuximide—CYP3A4—Raloxifene—breast cancer	0.0117	0.0214	CbGbCtD
Ethosuximide—CYP3A5—Docetaxel—breast cancer	0.0112	0.0204	CbGbCtD
Ethosuximide—CYP3A4—Vinorelbine—breast cancer	0.0086	0.0157	CbGbCtD
Ethosuximide—CYP3A4—Tamoxifen—breast cancer	0.00776	0.0142	CbGbCtD
Ethosuximide—CYP3A4—Mitoxantrone—breast cancer	0.00757	0.0138	CbGbCtD
Ethosuximide—CYP3A4—Paclitaxel—breast cancer	0.00604	0.011	CbGbCtD
Ethosuximide—CYP3A4—Irinotecan—breast cancer	0.00596	0.0109	CbGbCtD
Ethosuximide—CYP3A4—Vinblastine—breast cancer	0.0053	0.00967	CbGbCtD
Ethosuximide—CYP3A4—Docetaxel—breast cancer	0.00437	0.00797	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—breast cancer	0.00325	0.00594	CbGbCtD
Ethosuximide—Methyprylon—CYP2D6—breast cancer	0.0019	1	CrCbGaD
Ethosuximide—Rash—Goserelin—breast cancer	0.000129	0.00071	CcSEcCtD
Ethosuximide—Hypersensitivity—Thiotepa—breast cancer	0.000129	0.000709	CcSEcCtD
Ethosuximide—Dermatitis—Goserelin—breast cancer	0.000129	0.000709	CcSEcCtD
Ethosuximide—Mental disorder—Docetaxel—breast cancer	0.000128	0.000709	CcSEcCtD
Ethosuximide—Somnolence—Fluorouracil—breast cancer	0.000128	0.000708	CcSEcCtD
Ethosuximide—Immune system disorder—Capecitabine—breast cancer	0.000128	0.000707	CcSEcCtD
Ethosuximide—Mediastinal disorder—Capecitabine—breast cancer	0.000128	0.000706	CcSEcCtD
Ethosuximide—Headache—Goserelin—breast cancer	0.000128	0.000705	CcSEcCtD
Ethosuximide—Malnutrition—Docetaxel—breast cancer	0.000128	0.000704	CcSEcCtD
Ethosuximide—Decreased appetite—Gemcitabine—breast cancer	0.000128	0.000704	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000127	0.000703	CcSEcCtD
Ethosuximide—Nausea—Tamoxifen—breast cancer	0.000127	0.0007	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000127	0.000699	CcSEcCtD
Ethosuximide—Abdominal discomfort—Methotrexate—breast cancer	0.000127	0.000698	CcSEcCtD
Ethosuximide—Fatigue—Gemcitabine—breast cancer	0.000127	0.000698	CcSEcCtD
Ethosuximide—Decreased appetite—Fluorouracil—breast cancer	0.000125	0.000692	CcSEcCtD
Ethosuximide—Pancytopenia—Methotrexate—breast cancer	0.000125	0.000692	CcSEcCtD
Ethosuximide—Asthenia—Thiotepa—breast cancer	0.000125	0.000691	CcSEcCtD
Ethosuximide—Diarrhoea—Vinorelbine—breast cancer	0.000125	0.00069	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000125	0.000688	CcSEcCtD
Ethosuximide—Ataxia—Doxorubicin—breast cancer	0.000124	0.000686	CcSEcCtD
Ethosuximide—Mental disorder—Capecitabine—breast cancer	0.000124	0.000686	CcSEcCtD
Ethosuximide—Nausea—Melphalan—breast cancer	0.000124	0.000685	CcSEcCtD
Ethosuximide—Malnutrition—Capecitabine—breast cancer	0.000124	0.000682	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Irinotecan—breast cancer	0.000123	0.00068	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000123	0.00068	CcSEcCtD
Ethosuximide—Muscle spasms—Docetaxel—breast cancer	0.000123	0.000677	CcSEcCtD
Ethosuximide—Eosinophilia—Epirubicin—breast cancer	0.000122	0.000675	CcSEcCtD
Ethosuximide—Nausea—Goserelin—breast cancer	0.000121	0.000669	CcSEcCtD
Ethosuximide—Dizziness—Vinorelbine—breast cancer	0.000121	0.000667	CcSEcCtD
Ethosuximide—Abdominal pain upper—Doxorubicin—breast cancer	0.000121	0.000667	CcSEcCtD
Ethosuximide—Nervous system disorder—Paclitaxel—breast cancer	0.000121	0.000665	CcSEcCtD
Ethosuximide—Urticaria—Mitoxantrone—breast cancer	0.00012	0.000661	CcSEcCtD
Ethosuximide—Breast disorder—Doxorubicin—breast cancer	0.00012	0.00066	CcSEcCtD
Ethosuximide—Diarrhoea—Thiotepa—breast cancer	0.000119	0.000659	CcSEcCtD
Ethosuximide—Skin disorder—Paclitaxel—breast cancer	0.000119	0.000659	CcSEcCtD
Ethosuximide—Abdominal pain—Irinotecan—breast cancer	0.000119	0.000657	CcSEcCtD
Ethosuximide—Abdominal pain—Mitoxantrone—breast cancer	0.000119	0.000657	CcSEcCtD
Ethosuximide—Muscle spasms—Capecitabine—breast cancer	0.000119	0.000656	CcSEcCtD
Ethosuximide—Drowsiness—Methotrexate—breast cancer	0.000118	0.00065	CcSEcCtD
Ethosuximide—Pancytopenia—Epirubicin—breast cancer	0.000117	0.000647	CcSEcCtD
Ethosuximide—Anorexia—Paclitaxel—breast cancer	0.000117	0.000646	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000117	0.000644	CcSEcCtD
Ethosuximide—Vomiting—Vinorelbine—breast cancer	0.000116	0.000641	CcSEcCtD
Ethosuximide—Dizziness—Thiotepa—breast cancer	0.000115	0.000637	CcSEcCtD
Ethosuximide—Rash—Vinorelbine—breast cancer	0.000115	0.000636	CcSEcCtD
Ethosuximide—Dermatitis—Vinorelbine—breast cancer	0.000115	0.000635	CcSEcCtD
Ethosuximide—Urticaria—Fluorouracil—breast cancer	0.000115	0.000633	CcSEcCtD
Ethosuximide—Headache—Vinorelbine—breast cancer	0.000114	0.000632	CcSEcCtD
Ethosuximide—Leukopenia—Docetaxel—breast cancer	0.000114	0.00063	CcSEcCtD
Ethosuximide—Eosinophilia—Doxorubicin—breast cancer	0.000113	0.000625	CcSEcCtD
Ethosuximide—Haematuria—Methotrexate—breast cancer	0.000112	0.000619	CcSEcCtD
Ethosuximide—Weight decreased—Epirubicin—breast cancer	0.000112	0.000617	CcSEcCtD
Ethosuximide—Hypersensitivity—Mitoxantrone—breast cancer	0.000111	0.000613	CcSEcCtD
Ethosuximide—Hypersensitivity—Irinotecan—breast cancer	0.000111	0.000613	CcSEcCtD
Ethosuximide—Vomiting—Thiotepa—breast cancer	0.000111	0.000612	CcSEcCtD
Ethosuximide—Leukopenia—Capecitabine—breast cancer	0.000111	0.00061	CcSEcCtD
Ethosuximide—Drowsiness—Epirubicin—breast cancer	0.00011	0.000608	CcSEcCtD
Ethosuximide—Rash—Thiotepa—breast cancer	0.00011	0.000607	CcSEcCtD
Ethosuximide—Dermatitis—Thiotepa—breast cancer	0.00011	0.000607	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—breast cancer	0.00011	0.000606	CcSEcCtD
Ethosuximide—Headache—Thiotepa—breast cancer	0.000109	0.000603	CcSEcCtD
Ethosuximide—Somnolence—Paclitaxel—breast cancer	0.000109	0.000603	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000109	0.000603	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—breast cancer	0.000109	0.000599	CcSEcCtD
Ethosuximide—Nausea—Vinorelbine—breast cancer	0.000109	0.000599	CcSEcCtD
Ethosuximide—Asthenia—Mitoxantrone—breast cancer	0.000108	0.000597	CcSEcCtD
Ethosuximide—Asthenia—Irinotecan—breast cancer	0.000108	0.000597	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000108	0.000595	CcSEcCtD
Ethosuximide—Decreased appetite—Paclitaxel—breast cancer	0.000107	0.000589	CcSEcCtD
Ethosuximide—Hypersensitivity—Fluorouracil—breast cancer	0.000106	0.000587	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000106	0.000585	CcSEcCtD
Ethosuximide—Fatigue—Paclitaxel—breast cancer	0.000106	0.000585	CcSEcCtD
Ethosuximide—Asthenia—Gemcitabine—breast cancer	0.000105	0.000581	CcSEcCtD
Ethosuximide—Haematuria—Epirubicin—breast cancer	0.000105	0.00058	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000104	0.000577	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—breast cancer	0.000104	0.000576	CcSEcCtD
Ethosuximide—Nausea—Thiotepa—breast cancer	0.000104	0.000572	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—breast cancer	0.000104	0.000572	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—breast cancer	0.000103	0.000571	CcSEcCtD
Ethosuximide—Diarrhoea—Mitoxantrone—breast cancer	0.000103	0.000569	CcSEcCtD
Ethosuximide—Diarrhoea—Irinotecan—breast cancer	0.000103	0.000569	CcSEcCtD
Ethosuximide—Agranulocytosis—Epirubicin—breast cancer	0.000103	0.000567	CcSEcCtD
Ethosuximide—Nervous system disorder—Docetaxel—breast cancer	0.000102	0.000564	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—breast cancer	0.000102	0.000562	CcSEcCtD
Ethosuximide—Skin disorder—Docetaxel—breast cancer	0.000101	0.000558	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000101	0.000558	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Paclitaxel—breast cancer	0.000101	0.000555	CcSEcCtD
Ethosuximide—Diarrhoea—Gemcitabine—breast cancer	0.0001	0.000554	CcSEcCtD
Ethosuximide—Erythema multiforme—Methotrexate—breast cancer	9.99e-05	0.000551	CcSEcCtD
Ethosuximide—Dizziness—Irinotecan—breast cancer	9.97e-05	0.00055	CcSEcCtD
Ethosuximide—Anorexia—Docetaxel—breast cancer	9.93e-05	0.000548	CcSEcCtD
Ethosuximide—Nervous system disorder—Capecitabine—breast cancer	9.89e-05	0.000546	CcSEcCtD
Ethosuximide—Eye disorder—Methotrexate—breast cancer	9.88e-05	0.000545	CcSEcCtD
Ethosuximide—Diarrhoea—Fluorouracil—breast cancer	9.88e-05	0.000545	CcSEcCtD
Ethosuximide—Skin disorder—Capecitabine—breast cancer	9.8e-05	0.000541	CcSEcCtD
Ethosuximide—Urinary tract disorder—Epirubicin—breast cancer	9.77e-05	0.000539	CcSEcCtD
Ethosuximide—Urticaria—Paclitaxel—breast cancer	9.76e-05	0.000539	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—breast cancer	9.72e-05	0.000536	CcSEcCtD
Ethosuximide—Connective tissue disorder—Epirubicin—breast cancer	9.72e-05	0.000536	CcSEcCtD
Ethosuximide—Abdominal pain—Paclitaxel—breast cancer	9.72e-05	0.000536	CcSEcCtD
Ethosuximide—Urethral disorder—Epirubicin—breast cancer	9.7e-05	0.000535	CcSEcCtD
Ethosuximide—Anorexia—Capecitabine—breast cancer	9.61e-05	0.00053	CcSEcCtD
Ethosuximide—Vomiting—Irinotecan—breast cancer	9.58e-05	0.000529	CcSEcCtD
Ethosuximide—Vomiting—Mitoxantrone—breast cancer	9.58e-05	0.000529	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—breast cancer	9.55e-05	0.000527	CcSEcCtD
Ethosuximide—Dizziness—Fluorouracil—breast cancer	9.55e-05	0.000527	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—breast cancer	9.53e-05	0.000526	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—breast cancer	9.51e-05	0.000525	CcSEcCtD
Ethosuximide—Rash—Irinotecan—breast cancer	9.5e-05	0.000524	CcSEcCtD
Ethosuximide—Rash—Mitoxantrone—breast cancer	9.5e-05	0.000524	CcSEcCtD
Ethosuximide—Dermatitis—Irinotecan—breast cancer	9.49e-05	0.000524	CcSEcCtD
Ethosuximide—Dermatitis—Mitoxantrone—breast cancer	9.49e-05	0.000524	CcSEcCtD
Ethosuximide—Headache—Irinotecan—breast cancer	9.44e-05	0.000521	CcSEcCtD
Ethosuximide—Headache—Mitoxantrone—breast cancer	9.44e-05	0.000521	CcSEcCtD
Ethosuximide—Erythema multiforme—Epirubicin—breast cancer	9.35e-05	0.000516	CcSEcCtD
Ethosuximide—Vomiting—Gemcitabine—breast cancer	9.33e-05	0.000515	CcSEcCtD
Ethosuximide—Somnolence—Docetaxel—breast cancer	9.26e-05	0.000511	CcSEcCtD
Ethosuximide—Mental disorder—Methotrexate—breast cancer	9.26e-05	0.000511	CcSEcCtD
Ethosuximide—Rash—Gemcitabine—breast cancer	9.26e-05	0.000511	CcSEcCtD
Ethosuximide—Dermatitis—Gemcitabine—breast cancer	9.25e-05	0.00051	CcSEcCtD
Ethosuximide—Eye disorder—Epirubicin—breast cancer	9.24e-05	0.00051	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—breast cancer	9.2e-05	0.000508	CcSEcCtD
Ethosuximide—Headache—Gemcitabine—breast cancer	9.2e-05	0.000507	CcSEcCtD
Ethosuximide—Vomiting—Fluorouracil—breast cancer	9.18e-05	0.000506	CcSEcCtD
Ethosuximide—Rash—Fluorouracil—breast cancer	9.1e-05	0.000502	CcSEcCtD
Ethosuximide—Dermatitis—Fluorouracil—breast cancer	9.09e-05	0.000502	CcSEcCtD
Ethosuximide—Decreased appetite—Docetaxel—breast cancer	9.06e-05	0.0005	CcSEcCtD
Ethosuximide—Hypersensitivity—Paclitaxel—breast cancer	9.06e-05	0.0005	CcSEcCtD
Ethosuximide—Headache—Fluorouracil—breast cancer	9.04e-05	0.000499	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—breast cancer	9.04e-05	0.000499	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Docetaxel—breast cancer	8.99e-05	0.000496	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—breast cancer	8.99e-05	0.000496	CcSEcCtD
Ethosuximide—Fatigue—Docetaxel—breast cancer	8.98e-05	0.000496	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—breast cancer	8.97e-05	0.000495	CcSEcCtD
Ethosuximide—Nausea—Irinotecan—breast cancer	8.95e-05	0.000494	CcSEcCtD
Ethosuximide—Nausea—Mitoxantrone—breast cancer	8.95e-05	0.000494	CcSEcCtD
Ethosuximide—Immune system disorder—Epirubicin—breast cancer	8.93e-05	0.000493	CcSEcCtD
Ethosuximide—Mediastinal disorder—Epirubicin—breast cancer	8.91e-05	0.000492	CcSEcCtD
Ethosuximide—Asthenia—Paclitaxel—breast cancer	8.82e-05	0.000487	CcSEcCtD
Ethosuximide—Decreased appetite—Capecitabine—breast cancer	8.77e-05	0.000484	CcSEcCtD
Ethosuximide—Nausea—Gemcitabine—breast cancer	8.72e-05	0.000481	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Capecitabine—breast cancer	8.71e-05	0.00048	CcSEcCtD
Ethosuximide—Fatigue—Capecitabine—breast cancer	8.7e-05	0.00048	CcSEcCtD
Ethosuximide—Mental disorder—Epirubicin—breast cancer	8.67e-05	0.000478	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—breast cancer	8.65e-05	0.000477	CcSEcCtD
Ethosuximide—Malnutrition—Epirubicin—breast cancer	8.61e-05	0.000475	CcSEcCtD
Ethosuximide—Nausea—Fluorouracil—breast cancer	8.57e-05	0.000473	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—breast cancer	8.55e-05	0.000472	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Docetaxel—breast cancer	8.52e-05	0.00047	CcSEcCtD
Ethosuximide—Diarrhoea—Paclitaxel—breast cancer	8.41e-05	0.000464	CcSEcCtD
Ethosuximide—Muscle spasms—Epirubicin—breast cancer	8.28e-05	0.000457	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—breast cancer	8.27e-05	0.000456	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Capecitabine—breast cancer	8.25e-05	0.000455	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—breast cancer	8.25e-05	0.000455	CcSEcCtD
Ethosuximide—Abdominal pain—Docetaxel—breast cancer	8.24e-05	0.000454	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—breast cancer	8.24e-05	0.000454	CcSEcCtD
Ethosuximide—Dizziness—Paclitaxel—breast cancer	8.13e-05	0.000448	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—breast cancer	8.02e-05	0.000442	CcSEcCtD
Ethosuximide—Urticaria—Capecitabine—breast cancer	8.01e-05	0.000442	CcSEcCtD
Ethosuximide—Abdominal pain—Capecitabine—breast cancer	7.97e-05	0.00044	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—breast cancer	7.97e-05	0.00044	CcSEcCtD
Ethosuximide—Agitation—Epirubicin—breast cancer	7.91e-05	0.000437	CcSEcCtD
Ethosuximide—Vomiting—Paclitaxel—breast cancer	7.82e-05	0.000431	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.78e-05	0.000429	CcSEcCtD
Ethosuximide—Rash—Paclitaxel—breast cancer	7.75e-05	0.000428	CcSEcCtD
Ethosuximide—Dermatitis—Paclitaxel—breast cancer	7.74e-05	0.000427	CcSEcCtD
Ethosuximide—Leukopenia—Epirubicin—breast cancer	7.71e-05	0.000425	CcSEcCtD
Ethosuximide—Headache—Paclitaxel—breast cancer	7.7e-05	0.000425	CcSEcCtD
Ethosuximide—Hypersensitivity—Docetaxel—breast cancer	7.68e-05	0.000423	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—breast cancer	7.66e-05	0.000423	CcSEcCtD
Ethosuximide—Asthenia—Docetaxel—breast cancer	7.47e-05	0.000412	CcSEcCtD
Ethosuximide—Hypersensitivity—Capecitabine—breast cancer	7.43e-05	0.00041	CcSEcCtD
Ethosuximide—Nervous system disorder—Methotrexate—breast cancer	7.36e-05	0.000406	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—breast cancer	7.32e-05	0.000404	CcSEcCtD
Ethosuximide—Nausea—Paclitaxel—breast cancer	7.3e-05	0.000403	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—breast cancer	7.29e-05	0.000402	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.28e-05	0.000402	CcSEcCtD
Ethosuximide—Asthenia—Capecitabine—breast cancer	7.24e-05	0.000399	CcSEcCtD
Ethosuximide—Anorexia—Methotrexate—breast cancer	7.16e-05	0.000395	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—breast cancer	7.13e-05	0.000393	CcSEcCtD
Ethosuximide—Diarrhoea—Docetaxel—breast cancer	7.13e-05	0.000393	CcSEcCtD
Ethosuximide—Diarrhoea—Capecitabine—breast cancer	6.9e-05	0.000381	CcSEcCtD
Ethosuximide—Nervous system disorder—Epirubicin—breast cancer	6.89e-05	0.00038	CcSEcCtD
Ethosuximide—Dizziness—Docetaxel—breast cancer	6.89e-05	0.00038	CcSEcCtD
Ethosuximide—Skin disorder—Epirubicin—breast cancer	6.83e-05	0.000377	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.74e-05	0.000372	CcSEcCtD
Ethosuximide—Anorexia—Epirubicin—breast cancer	6.7e-05	0.00037	CcSEcCtD
Ethosuximide—Somnolence—Methotrexate—breast cancer	6.68e-05	0.000368	CcSEcCtD
Ethosuximide—Dizziness—Capecitabine—breast cancer	6.67e-05	0.000368	CcSEcCtD
Ethosuximide—Vomiting—Docetaxel—breast cancer	6.62e-05	0.000365	CcSEcCtD
Ethosuximide—Rash—Docetaxel—breast cancer	6.57e-05	0.000362	CcSEcCtD
Ethosuximide—Dermatitis—Docetaxel—breast cancer	6.56e-05	0.000362	CcSEcCtD
Ethosuximide—Decreased appetite—Methotrexate—breast cancer	6.53e-05	0.00036	CcSEcCtD
Ethosuximide—Headache—Docetaxel—breast cancer	6.53e-05	0.00036	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—breast cancer	6.48e-05	0.000358	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—breast cancer	6.47e-05	0.000357	CcSEcCtD
Ethosuximide—Vomiting—Capecitabine—breast cancer	6.41e-05	0.000354	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—breast cancer	6.38e-05	0.000352	CcSEcCtD
Ethosuximide—Rash—Capecitabine—breast cancer	6.36e-05	0.000351	CcSEcCtD
Ethosuximide—Dermatitis—Capecitabine—breast cancer	6.35e-05	0.000351	CcSEcCtD
Ethosuximide—Headache—Capecitabine—breast cancer	6.32e-05	0.000349	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—breast cancer	6.32e-05	0.000348	CcSEcCtD
Ethosuximide—Somnolence—Epirubicin—breast cancer	6.25e-05	0.000345	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—breast cancer	6.2e-05	0.000342	CcSEcCtD
Ethosuximide—Nausea—Docetaxel—breast cancer	6.19e-05	0.000341	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methotrexate—breast cancer	6.14e-05	0.000339	CcSEcCtD
Ethosuximide—Decreased appetite—Epirubicin—breast cancer	6.11e-05	0.000337	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Epirubicin—breast cancer	6.07e-05	0.000335	CcSEcCtD
Ethosuximide—Fatigue—Epirubicin—breast cancer	6.06e-05	0.000334	CcSEcCtD
Ethosuximide—Nausea—Capecitabine—breast cancer	5.99e-05	0.000331	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—breast cancer	5.97e-05	0.000329	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—breast cancer	5.94e-05	0.000327	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—breast cancer	5.78e-05	0.000319	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Epirubicin—breast cancer	5.75e-05	0.000317	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—breast cancer	5.65e-05	0.000312	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—breast cancer	5.61e-05	0.00031	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—breast cancer	5.61e-05	0.000309	CcSEcCtD
Ethosuximide—Urticaria—Epirubicin—breast cancer	5.58e-05	0.000308	CcSEcCtD
Ethosuximide—Abdominal pain—Epirubicin—breast cancer	5.56e-05	0.000306	CcSEcCtD
Ethosuximide—Hypersensitivity—Methotrexate—breast cancer	5.53e-05	0.000305	CcSEcCtD
Ethosuximide—Asthenia—Methotrexate—breast cancer	5.39e-05	0.000297	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Doxorubicin—breast cancer	5.32e-05	0.000293	CcSEcCtD
Ethosuximide—Hypersensitivity—Epirubicin—breast cancer	5.18e-05	0.000286	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—breast cancer	5.17e-05	0.000285	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—breast cancer	5.14e-05	0.000284	CcSEcCtD
Ethosuximide—Diarrhoea—Methotrexate—breast cancer	5.14e-05	0.000283	CcSEcCtD
Ethosuximide—Asthenia—Epirubicin—breast cancer	5.04e-05	0.000278	CcSEcCtD
Ethosuximide—Dizziness—Methotrexate—breast cancer	4.97e-05	0.000274	CcSEcCtD
Ethosuximide—Diarrhoea—Epirubicin—breast cancer	4.81e-05	0.000265	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—breast cancer	4.79e-05	0.000264	CcSEcCtD
Ethosuximide—Vomiting—Methotrexate—breast cancer	4.77e-05	0.000263	CcSEcCtD
Ethosuximide—Rash—Methotrexate—breast cancer	4.73e-05	0.000261	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—breast cancer	4.73e-05	0.000261	CcSEcCtD
Ethosuximide—Headache—Methotrexate—breast cancer	4.7e-05	0.00026	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—breast cancer	4.67e-05	0.000257	CcSEcCtD
Ethosuximide—Dizziness—Epirubicin—breast cancer	4.65e-05	0.000256	CcSEcCtD
Ethosuximide—Vomiting—Epirubicin—breast cancer	4.47e-05	0.000246	CcSEcCtD
Ethosuximide—Nausea—Methotrexate—breast cancer	4.46e-05	0.000246	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—breast cancer	4.45e-05	0.000245	CcSEcCtD
Ethosuximide—Rash—Epirubicin—breast cancer	4.43e-05	0.000244	CcSEcCtD
Ethosuximide—Dermatitis—Epirubicin—breast cancer	4.43e-05	0.000244	CcSEcCtD
Ethosuximide—Headache—Epirubicin—breast cancer	4.4e-05	0.000243	CcSEcCtD
Ethosuximide—Dizziness—Doxorubicin—breast cancer	4.3e-05	0.000237	CcSEcCtD
Ethosuximide—Nausea—Epirubicin—breast cancer	4.17e-05	0.00023	CcSEcCtD
Ethosuximide—Vomiting—Doxorubicin—breast cancer	4.13e-05	0.000228	CcSEcCtD
Ethosuximide—Rash—Doxorubicin—breast cancer	4.1e-05	0.000226	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—breast cancer	4.1e-05	0.000226	CcSEcCtD
Ethosuximide—Headache—Doxorubicin—breast cancer	4.07e-05	0.000225	CcSEcCtD
Ethosuximide—Nausea—Doxorubicin—breast cancer	3.86e-05	0.000213	CcSEcCtD
Ethosuximide—CYP3A5—Metabolism—GSTA4—breast cancer	1.42e-05	0.000152	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ACHE—breast cancer	1.41e-05	0.000152	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTT1—breast cancer	1.41e-05	0.000152	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA2—breast cancer	1.39e-05	0.000149	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GPX2—breast cancer	1.39e-05	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA2—breast cancer	1.38e-05	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GPX2—breast cancer	1.38e-05	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NOS3—breast cancer	1.38e-05	0.000148	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GPX4—breast cancer	1.37e-05	0.000147	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SULT1A1—breast cancer	1.37e-05	0.000147	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SULT1A1—breast cancer	1.37e-05	0.000147	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GPX4—breast cancer	1.37e-05	0.000147	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.35e-05	0.000145	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP17A1—breast cancer	1.34e-05	0.000144	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—IDH1—breast cancer	1.34e-05	0.000143	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA1—breast cancer	1.34e-05	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—IDH1—breast cancer	1.33e-05	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA1—breast cancer	1.33e-05	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ENO1—breast cancer	1.33e-05	0.000142	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS1—breast cancer	1.33e-05	0.000142	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NAT2—breast cancer	1.32e-05	0.000142	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NAT2—breast cancer	1.32e-05	0.000141	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2D6—breast cancer	1.3e-05	0.000139	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOA2—breast cancer	1.28e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CB—breast cancer	1.27e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—breast cancer	1.26e-05	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NDUFS3—breast cancer	1.26e-05	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—FASN—breast cancer	1.24e-05	0.000133	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—BCHE—breast cancer	1.23e-05	0.000132	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC5A5—breast cancer	1.22e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CHST9—breast cancer	1.18e-05	0.000127	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NQO1—breast cancer	1.18e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC2A1—breast cancer	1.18e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—DPYD—breast cancer	1.16e-05	0.000124	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MED12—breast cancer	1.16e-05	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MED12—breast cancer	1.16e-05	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—DPYD—breast cancer	1.16e-05	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP3A4—breast cancer	1.15e-05	0.000123	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDOA—breast cancer	1.14e-05	0.000122	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDOA—breast cancer	1.14e-05	0.000122	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1B1—breast cancer	1.13e-05	0.000121	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—COX11—breast cancer	1.12e-05	0.00012	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOA3—breast cancer	1.11e-05	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HSP90AA1—breast cancer	1.11e-05	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOA3—breast cancer	1.11e-05	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTEN—breast cancer	1.1e-05	0.000118	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A2—breast cancer	1.1e-05	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A2—breast cancer	1.1e-05	0.000118	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CPT1A—breast cancer	1.08e-05	0.000116	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTR—breast cancer	1.08e-05	0.000116	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCG2—breast cancer	1.08e-05	0.000116	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOA1—breast cancer	1.08e-05	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CPT1A—breast cancer	1.08e-05	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTR—breast cancer	1.08e-05	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCG2—breast cancer	1.08e-05	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—STK11—breast cancer	1.06e-05	0.000114	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP19A1—breast cancer	1.06e-05	0.000114	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HPGDS—breast cancer	1.06e-05	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HPGDS—breast cancer	1.05e-05	0.000113	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HBA1—breast cancer	1.05e-05	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HBA1—breast cancer	1.05e-05	0.000112	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTT1—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ACHE—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SHMT1—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CDA—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ACHE—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTT1—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—COMT—breast cancer	9.85e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.85e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A5—breast cancer	9.85e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTP1—breast cancer	9.81e-06	0.000105	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP17A1—breast cancer	9.7e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP17A1—breast cancer	9.68e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMOX1—breast cancer	9.67e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ITPR1—breast cancer	9.65e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS1—breast cancer	9.6e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ENO1—breast cancer	9.6e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS1—breast cancer	9.58e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ENO1—breast cancer	9.58e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APRT—breast cancer	9.51e-06	0.000102	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2D6—breast cancer	9.42e-06	0.000101	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2D6—breast cancer	9.4e-06	0.000101	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCB1—breast cancer	9.28e-06	9.96e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOA2—breast cancer	9.24e-06	9.92e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOA2—breast cancer	9.22e-06	9.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TYMS—breast cancer	9.12e-06	9.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTM1—breast cancer	9.01e-06	9.67e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOR1—breast cancer	9.01e-06	9.67e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLA2G4A—breast cancer	9.01e-06	9.67e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—FASN—breast cancer	8.96e-06	9.62e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ESRRA—breast cancer	8.95e-06	9.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.95e-06	9.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—FASN—breast cancer	8.95e-06	9.6e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BCHE—breast cancer	8.93e-06	9.58e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BCHE—breast cancer	8.91e-06	9.56e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC5A5—breast cancer	8.82e-06	9.46e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC5A5—breast cancer	8.8e-06	9.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GPX1—breast cancer	8.63e-06	9.26e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1A1—breast cancer	8.54e-06	9.16e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A1—breast cancer	8.52e-06	9.14e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NQO1—breast cancer	8.52e-06	9.14e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A1—breast cancer	8.5e-06	9.12e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NQO1—breast cancer	8.5e-06	9.12e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HADHB—breast cancer	8.48e-06	9.1e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPI—breast cancer	8.48e-06	9.1e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ERCC2—breast cancer	8.47e-06	9.09e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP3A4—breast cancer	8.3e-06	8.91e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP3A4—breast cancer	8.29e-06	8.89e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1B1—breast cancer	8.16e-06	8.76e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1B1—breast cancer	8.15e-06	8.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.09e-06	8.68e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.09e-06	8.68e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSP90AA1—breast cancer	8.01e-06	8.59e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSP90AA1—breast cancer	7.99e-06	8.57e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTHFR—breast cancer	7.96e-06	8.54e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOA1—breast cancer	7.79e-06	8.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOA1—breast cancer	7.77e-06	8.34e-05	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—breast cancer	7.76e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—FHL2—breast cancer	7.76e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NME1—breast cancer	7.76e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADSL—breast cancer	7.76e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PHGDH—breast cancer	7.76e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UMPS—breast cancer	7.76e-06	8.32e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—STK11—breast cancer	7.68e-06	8.24e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP19A1—breast cancer	7.68e-06	8.24e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—STK11—breast cancer	7.66e-06	8.22e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP19A1—breast cancer	7.66e-06	8.22e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BRIP1—breast cancer	7.61e-06	8.16e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LDHB—breast cancer	7.61e-06	8.16e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HPSE—breast cancer	7.61e-06	8.16e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAV1—breast cancer	7.35e-06	7.88e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA3—breast cancer	7.21e-06	7.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMMR—breast cancer	7.21e-06	7.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCC1—breast cancer	7.21e-06	7.74e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—COMT—breast cancer	7.14e-06	7.66e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—COMT—breast cancer	7.12e-06	7.64e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTP1—breast cancer	7.1e-06	7.62e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTP1—breast cancer	7.09e-06	7.6e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMOX1—breast cancer	7e-06	7.52e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMOX1—breast cancer	6.99e-06	7.5e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ITPR1—breast cancer	6.99e-06	7.5e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.98e-06	7.49e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ITPR1—breast cancer	6.97e-06	7.48e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCB1—breast cancer	6.72e-06	7.21e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCB1—breast cancer	6.71e-06	7.2e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CG—breast cancer	6.69e-06	7.18e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TYMS—breast cancer	6.6e-06	7.08e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA4—breast cancer	6.6e-06	7.08e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA9—breast cancer	6.6e-06	7.08e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TYMS—breast cancer	6.59e-06	7.07e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOR1—breast cancer	6.53e-06	7e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLA2G4A—breast cancer	6.53e-06	7e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTM1—breast cancer	6.53e-06	7e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTM1—breast cancer	6.51e-06	6.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOR1—breast cancer	6.51e-06	6.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLA2G4A—breast cancer	6.51e-06	6.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPX2—breast cancer	6.43e-06	6.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA2—breast cancer	6.43e-06	6.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SULT1A1—breast cancer	6.35e-06	6.81e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPX4—breast cancer	6.35e-06	6.81e-05	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—breast cancer	6.34e-06	6.8e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GPX1—breast cancer	6.25e-06	6.71e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GPX1—breast cancer	6.24e-06	6.69e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA1—breast cancer	6.2e-06	6.65e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—IDH1—breast cancer	6.2e-06	6.65e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1A1—breast cancer	6.19e-06	6.64e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1A1—breast cancer	6.17e-06	6.62e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ERCC2—breast cancer	6.14e-06	6.58e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NAT2—breast cancer	6.13e-06	6.58e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ERCC2—breast cancer	6.12e-06	6.57e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CD—breast cancer	5.88e-06	6.31e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—breast cancer	5.81e-06	6.23e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTHFR—breast cancer	5.77e-06	6.19e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTHFR—breast cancer	5.76e-06	6.18e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NOS3—breast cancer	5.55e-06	5.96e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—DPYD—breast cancer	5.38e-06	5.77e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MED12—breast cancer	5.38e-06	5.77e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAV1—breast cancer	5.32e-06	5.71e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAV1—breast cancer	5.31e-06	5.7e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDOA—breast cancer	5.29e-06	5.68e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOA3—breast cancer	5.14e-06	5.51e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CB—breast cancer	5.13e-06	5.5e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A2—breast cancer	5.1e-06	5.47e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—breast cancer	5.08e-06	5.45e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CPT1A—breast cancer	5e-06	5.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTR—breast cancer	5e-06	5.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCG2—breast cancer	5e-06	5.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HPGDS—breast cancer	4.9e-06	5.26e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HBA1—breast cancer	4.87e-06	5.23e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CG—breast cancer	4.85e-06	5.2e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CG—breast cancer	4.84e-06	5.19e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTT1—breast cancer	4.75e-06	5.1e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ACHE—breast cancer	4.75e-06	5.1e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP17A1—breast cancer	4.5e-06	4.83e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS1—breast cancer	4.45e-06	4.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENO1—breast cancer	4.45e-06	4.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTEN—breast cancer	4.43e-06	4.75e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2D6—breast cancer	4.37e-06	4.69e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOA2—breast cancer	4.29e-06	4.6e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CD—breast cancer	4.26e-06	4.57e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CD—breast cancer	4.25e-06	4.56e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—breast cancer	4.21e-06	4.51e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—breast cancer	4.2e-06	4.5e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—FASN—breast cancer	4.16e-06	4.46e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BCHE—breast cancer	4.14e-06	4.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC5A5—breast cancer	4.09e-06	4.39e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NOS3—breast cancer	4.02e-06	4.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NOS3—breast cancer	4.01e-06	4.31e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NQO1—breast cancer	3.95e-06	4.24e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A1—breast cancer	3.95e-06	4.24e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1B1—breast cancer	3.79e-06	4.06e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.71e-06	3.99e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CB—breast cancer	3.71e-06	3.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CB—breast cancer	3.71e-06	3.98e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—breast cancer	3.68e-06	3.95e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—breast cancer	3.67e-06	3.94e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOA1—breast cancer	3.61e-06	3.88e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—STK11—breast cancer	3.56e-06	3.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP19A1—breast cancer	3.56e-06	3.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—COMT—breast cancer	3.31e-06	3.55e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTP1—breast cancer	3.3e-06	3.54e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMOX1—breast cancer	3.25e-06	3.49e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ITPR1—breast cancer	3.24e-06	3.48e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTEN—breast cancer	3.21e-06	3.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTEN—breast cancer	3.2e-06	3.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—breast cancer	3.13e-06	3.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCB1—breast cancer	3.12e-06	3.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TYMS—breast cancer	3.06e-06	3.29e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOR1—breast cancer	3.03e-06	3.25e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.03e-06	3.25e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTM1—breast cancer	3.03e-06	3.25e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPX1—breast cancer	2.9e-06	3.11e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1A1—breast cancer	2.87e-06	3.08e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ERCC2—breast cancer	2.85e-06	3.05e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTHFR—breast cancer	2.68e-06	2.87e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—breast cancer	2.55e-06	2.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAV1—breast cancer	2.47e-06	2.65e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—breast cancer	2.26e-06	2.43e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—breast cancer	2.26e-06	2.42e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CG—breast cancer	2.25e-06	2.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.98e-06	2.12e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—breast cancer	1.95e-06	2.09e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NOS3—breast cancer	1.87e-06	2e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—breast cancer	1.85e-06	1.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—breast cancer	1.85e-06	1.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.72e-06	1.85e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—breast cancer	1.71e-06	1.83e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTEN—breast cancer	1.49e-06	1.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—breast cancer	1.05e-06	1.13e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—breast cancer	8.58e-07	9.21e-06	CbGpPWpGaD
